I've never once encouraged the purchase of a single AVXL share by anyone.
That should be a personal decision based upon ones risk, reward, and technical validity perspectives. Those who question in any way the described science of Anavex 2-73 shouldn't even be reading any of the posts on this board. Anavex Life Sciences Corp is a start-up pharmaceutical with no FDA-approved products or their derived revenues.
For those who wish to invest in such a company, the validity and future of the company's proprietary molecules must be confidently ascertained. Without such knowledge or belief, AVXL is just another new-drug crap shoot, which may or may not pan out. Why, might I ask, would anyone without firm confidence in the developing Anavex story have any interest whatsoever in this so-questionable play?
Of course, some institutional (stock fund) buyers have done their research and forked over hundreds of thousands of dollars, taking substantial corporate positions in Anavex Life Sciences Corp. Whether or not any of that influences ones perspectives on Anavex is an open question.
Again, I've never suggested that anyone buy even a single share of AVXL. I've laid out, in clear, concise language the unique neuron chemistry and physiology of the company's sigma-1 receptor agonist, telling how it is able to stabilize or reverse neuron dysfunction. Some might think I'm making that all up, that it's still questionable. I care not. I'm certain of the company's molecular and cellular mechanisms, for which I've taken a personal equity position. That applies only to me, and should not be in any way the basis for anyone else's AVXL buy or sell perspectives.
Everyone should perform his own due diligence. If there is any question, absolutely stay away from Anavex. Don't lose any sleep or dollars with such a questionable equity position. If you have doubts about Anavex, you are in good, otherwise reputable company. Lots of financial advisors have claimed Anavex has no better chance of an Alzheimer's treatment than the many other previous pharmaceuticals who have lost literally billions in trying to solve the problem.
If you've got questions about the validity of the Anavex story or future, this by no means is the place to spend any time reading posts such as mine. How could my info have any due-diligence application? I'm merely a retired biology teacher claiming to understand and convey the elements of the molecular and cytological mechanisms of Anavex 2-73 in the dysfunctional neuron.
